Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Methotrexate | 0.31623 | uM | 5 | 312.50 | 138.75 | 161.00 | 185.00 | 0.8703 | 0.4310 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 5 | 312.50 | 138.75 | 192.00 | 185.00 | 1.0378 | 1.1872 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 5 | 312.50 | 138.75 | 215.00 | 185.00 | 1.1622 | 1.8727 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 5 | 312.50 | 138.75 | 124.00 | 185.00 | 0.6703 | -0.2372 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 274.00 | 185.00 | 1.4811 | 4.1526 | |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 5 | 312.50 | 138.75 | 114.00 | 185.00 | 0.6162 | -0.3771 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 5 | 312.50 | 138.75 | 205.00 | 185.00 | 1.1081 | 1.5612 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 207.00 | 185.00 | 1.1189 | 1.6218 | |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 5 | 312.50 | 138.75 | 163.00 | 185.00 | 0.8811 | 0.4742 |
| SK-BR-3 | Taxol | 0.1 | uM | 5 | 312.50 | 138.75 | 164.00 | 185.00 | 0.8865 | 0.4961 |
| SK-BR-3 | Taxol | 0.001 | uM | 5 | 312.50 | 138.75 | 255.00 | 185.00 | 1.3784 | 3.3334 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 5 | 312.50 | 138.75 | 165.00 | 185.00 | 0.8919 | 0.5181 |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 5 | 312.50 | 138.75 | 191.00 | 185.00 | 1.0324 | 1.1599 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 5 | 312.50 | 138.75 | 206.00 | 185.00 | 1.1135 | 1.5914 |
| SK-BR-3 | Omipalisib | 10 | uM | 5 | 312.50 | 138.75 | 136.00 | 185.00 | 0.7351 | -0.0471 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 301.00 | 185.00 | 1.6270 | 5.4620 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 179.00 | 185.00 | 0.9676 | 0.8473 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 503.00 | 673.25 | 0.7471 | 0.5515 | |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 649.00 | 673.25 | 0.9640 | 0.9371 | |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 5 | 625.00 | 303.79 | 719.00 | 673.25 | 1.0680 | 1.1179 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 5 | 625.00 | 303.79 | 732.00 | 673.25 | 1.0873 | 1.1512 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 5 | 625.00 | 303.79 | 616.00 | 673.25 | 0.9150 | 0.8510 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 5 | 625.00 | 303.79 | 324.00 | 673.25 | 0.4813 | 0.0577 |
| SK-BR-3 | Palbociclib | 0.0033113 | uM | 5 | 625.00 | 303.79 | 580.00 | 673.25 | 0.8615 | 0.7564 |
| SK-BR-3 | 0 | uM | 5 | 625.00 | 303.79 | 624.00 | 673.25 | 0.9269 | 0.8719 |